Senores Pharmaceuticals Subsidiary Successfully Completes USFDA Inspection at Vadodara Facility
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 11 Sept 2026, 7:12 pm
Senores Pharmaceuticals Subsidiary Successfully Completes USFDA Inspection at Vadodara Facility The USFDA successfully completed an inspection at the Vadodara manufacturing facility of Apnar Pharma Private Limited, a subsidiary of Senores Pharmaceuticals Limited. Conducted from 7th Sep'26 to 11th Sep'26, the audit concluded with zero GMP-related observations and only one minor procedural observation. The subsidiary will submit its formal response within the stipulated timeframe, posing minimal regulatory risk to ongoing manufacturing operations.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
